Bloodless Heart Transplant in CIMS Hospital Ahmedabad
Newzdaddy Health Care Updates
Marengo CIMS Hospital in Ahmedabad, part of the Marengo Asia Hospitals Group, has accomplished a remarkable medical milestone by performing Asia’s first bloodless heart transplant. This groundbreaking procedure utilizes a unique bleeding management protocol, allowing patients to recover in just nine to twelve days, significantly shorter than the typical 21 to 24 days required for conventional heart transplant patients.
The surgery, led by a team of skilled medical professionals including Dr. Dhiren Shah, Director of the Heart Transplant Program, Dr. Dhaval Naik, Heart Transplant Surgeon, Dr. Niren Bhavsar, Cardiothoracic Anesthetist, and Dr. Chintan Seth, Heart Transplant Anesthetist and Intensivist, was successfully performed on a 52-year-old patient with end-stage heart failure. This innovative procedure eliminates the need for blood transfusions, which can pose risks and complications for patients.
Marengo CIMS Hospital’s success is attributed to meticulous surgical techniques and tailored protocols that minimize surgical blood loss, ultimately eliminating the need for blood transfusions. Achieving a bloodless heart transplant is a complex and highly precise process that demands a high level of medical expertise.
Notably, the patient who underwent this groundbreaking therapy was discharged in just nine days, a significant improvement compared to the standard recovery time. This achievement places Marengo CIMS Hospital among the top 10 global institutions capable of performing bloodless heart transplants, offering hope for patients who cannot accept external blood transfusions.
Dr. Dhiren Shah, Director of the Heart Transplant Program, expressed the importance of this achievement in advancing surgical techniques and technology, emphasizing the adoption of Goal-directed bleeding Management (GDBM) to reduce blood transfusions, complications, and hospital stay.
Dr. Niren Bhavsar, Cardiothoracic Anesthetist, explained the critical role of the anaesthetist in avoiding the need for blood transfusions, ensuring the patient’s stability throughout the surgery, and managing blood loss.
Dr. Chintan Seth, Heart Transplant Anesthetist and Intensivist, highlighted the postoperative benefits of the bloodless procedure, with the patient’s smooth recovery and early discharge.
Dr. Raajiv Singhal, Managing Director & Group CEO of Marengo Asia Hospitals, commended the hospital’s pioneering efforts in advanced healthcare and pledged to extend this technology to other hospitals in the group, prioritizing patient safety and health.
Marengo CIMS Hospital has also established a Coagulation and Hemostasis Lab in partnership with Werfen as part of their commitment to excellence in cardiology, stroke, and trauma care.
Dr. Keyur Parikh, Chairman of Marengo CIMS Hospital, emphasized the hospital’s dedication to introducing innovative medical procedures while keeping the patient at the forefront of their mission.
Anurag Mishra, Regional Director of Werfen, expressed commitment to advancing Patient Blood Management, a multidisciplinary approach that reduces the need for blood transfusions in high-bleeding surgical procedures, improving patient outcomes. This approach aligns with the World Health Organization’s recommendations for safe and effective healthcare.
In conclusion, Marengo CIMS Hospital’s bloodless heart transplant is a significant achievement that represents a leap forward in cardiac surgery, reducing complications and improving patient outcomes. It underscores the hospital’s commitment to innovation and patient-centred care.
Also Read:
Transforming Lung Disorder Care in Ahmedabad
A Remarkable Success Story in the Battle Against a Football-Sized Tumor
